Appointment of Joseph Antoun as Adjunct Faculty Marks Buck Institute's First Foray Into Public Policy

October 3, 2011  Novato, CA  Joseph Antoun, MD has been appointed Adjunct Professor of Health and Public Policy at the Buck Institute.  Antoun is a cross-national/comparative health policy expert who will be primarily involved with the Buck Institute’s PhD program in aging, which is currently under development.

Prior to his appointment  Antoun was the Public Policy and Strategic Development Leader for Emerging and Developing Markets at Eli Lilly and Company. He is President and CEO of Health Systems Reform  S.A.L., a boutique consultancy aimed at improving public health through health policy.  Antoun is the co-Director of the Center for Health Policy at the University of Chicago where he teaches Health Systems and Pharmaceutical Policy. He is also a visiting fellow in the Department of Social Policy at the London School of Economics and Political Science.

“I am very impressed with the Buck Institute’s increased focus on global health and its efforts to impact the demographics of aging societies,” said Antoun. “I look forward to bringing a public policy perspective to their mission to extend the healthy years of life and to their expanding educational programs. I am excited to work with both the scientific staff and students studying at the Buck.”

“The scope of the Institute was always envisioned to range from biomedical research to social policy and Joseph Antoun is the perfect person to take us into the policy arena,” said Buck Institute President and CEO, Brian K. Kennedy, PhD. “ The work in our labs and the expansion of our educational programs needs to be put in a context that highlights the impact we hope to have on global health. At the same time, we want to make sure that public policy includes an ‘aging’ perspective. I am excited to work with Joseph on all of these issues."

Antoun got his MD from Saint Joseph University in Beirut, Lebanon. He received a Masters’ in Public Policy from Harvard University and has completed Health System Financing and Management studies at Johns Hopkins University. His recent research and teaching activities focused on health systems and system reform in the Middle East and ex-Soviet countries. He has numerous publications and is currently writing a book on health systems and systems reform.

About the Buck Institute for Research on Aging
The Buck Institute is the first freestanding institute in the United States that is devoted solely to basic research on aging and age-associated disease. The Institute is an independent nonprofit organization dedicated to extending the healthspan, the healthy years of each individual’s life. Buck Institute scientists work in an innovative, interdisciplinary setting to understand the mechanisms of aging and to discover new ways of detecting, preventing and treating conditions such as Alzheimer’s and Parkinson’s disease, cancer, diabetes, cardiovascular disease, macular degeneration and stroke.  For more information:

Change text size: